IP Verse

Compositions Comprising Cross-Species-Specific Antibodies And Uses Thereof

Patent No. EP1940881 (titled "Compositions Comprising Cross-Species-Specific Antibodies And Uses Thereof") was filed by Amgen Research Munich on Oct 10, 2006. The application was issued on Nov 30, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
APTEVO RESEARCHAug 30, 2017FORRESTERS
MORPHOSYSAug 30, 2017SPILLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1940881

AMGEN RESEARCH MUNICH
Application Number
EP06806155A
Filing Date
Oct 10, 2006
Status
Revoked
Mar 10, 2023
Publication Date
Nov 30, 2016
External Links
Slate, Register , Google Patents